A stereocontrolled procedure is reported for the access of various fluorine-containing piperidine and azepane β-amino esters. The synthetic protocol starts from readily available unsaturated cycloalkene β-amino acids and is based on oxidative cleavage of the ring olefin bond followed by ring closing of the diformyl intermediates in the presence of some fluorine-containing amines across reductive amination.
Introduction
Cyclic β-amino acids are considered to be novel compounds in the field of synthetic and medicinal chemistry and they have exerted increasing interest during the past twenty years because of the importance of some antifungal, antibacterial or analgetic small molecules. Despite of this, they might gain high relevance in the future, which is due to the important role of some functionalized counterparts in drug research. provides better bioavailability to a certain molecule. Moreover, perfluorocarbons are characterized by biological inertness, however they exhibit intense hydrophobic and lipophilic effects.
Results and Discussion
Because of the high biological importance of saturated azaheterocycles, our current ai was to combine β-amino acid and organofluorine molecular entities and synthesize novel molecular structures. This manuscript is intended to offer an insight into the extension of our earlier work 9a based on stereocontrolled synthesis of fluorine-containing piperidine or azepane β-amino acid derivatives. The synthetic approach included the use of some commercially available fluorinated or polyfluorinated primary amines and was based on the oxidative ring cleavage of unsaturated cyclic β-amino esters through the ring olefin bond (through vicinal diol). It is followed by ring closing by double reductive amination giving the products across ring expansion of the diformyl intermediates.
9
Cyclopentene cis-β-amino acid (±)-14 was first converted by esterification according to the route described earlier 10 , followed by N-protection and cis-dihydroxylation with the OsO4/NMO system to the corresponding dihydroxylated cis amino ester (±)-15. This diol was submitted to oxidative ring opening with NaIO4 in THF/H2O affording the corresponding acylic diformyl amino ester (±)-16. This relatively unstable dialdehyde derivative was further used in the forthcoming step without isolation. Thus (±)-16 was subjected to double-reductive amination with various commercially available fluorinated primary amines such as 2, 2,3,3,4,4,5,5,5-nonafluoropentan-1-amine, 2,2,3,3,4,4,5,5,6,6,7,7 ,7-tridecafluoroheptan-1-amine and 1,1,1-trifluoropropan-2-amine.
The reaction was induced with NaBH3CN in the presence of CH2Cl2. Ring closing involves reductive amination and gives the corresponding fluorinated or perfluorinated cis β-amino esters with a piperidine ring system ((±)-17a-c) (Scheme 1).
Scheme 1. Synthesis of fluorinated piperidine cis-β-amino esters.
amino ester fluorinecontaining amine product yield (two steps) 13%, (±)-17a
14%, (±)-17b
21%, (±)-17c Table 1 . Synthesis of piperidine cis-β-amino esters 17a-c.
Since the configuration of the stereocenters at C-1 and C-2 of amino esters (±)-14 and (±)-15 were not affected during the ring closing procedure, the integrity of the configuration of the chiral centers in (±)-17a-c was conserved, that is configurations are predetermined by the structure of the starting materials.
Accordingly, cis amino ester provided the corresponding piperidine derivative with the carboxylate and carbamate functions at C-3 and C-4 in a cis relative arrangement (Scheme 1, Table 1 ). Noteworthy, that the cyclization reaction performed with 1,1,1-trifluoropropan-2-amine as the amine source containing a chiral center yielded only a single piperidine compound ((±)-17b).
In continuation, cis isomer (±)-15 was converted to cyclopentene trans-β-amino acid (±)-18 9a,10 in an analogous way. Namely, compound (±)-15 with the ester and the carbamate groups in a trans relationship was subjected to oxidative ring opening with NaIO4. Table 2 ). Note, contrary to its cis counterpart compound (±)-20a proved to be unstable. Again, the reaction took place with stereocontrol with the conservation of the configuration of the chiral centers C-1 and C-2 of (±)-18 corresponding to C-3 and C-4 in products (±)-20a,b (Scheme 2, Table 2 ). Table 3 ) in the presence of NaBH3CN. The process proceeds through stereocontrol affording the corresponding cis azepane amino esters (±)-24a-e (Scheme 3).
Thus, applying the oxidative ring opening/ring closure with reductive amination protocol, a series of mono-, di-or trifluorinated as well as perfluorinated seven-membered N-heterocyclic cis amino esters could be accessed. are not affected during the process, they will predetermine the configuration of the chiral centers in the azaheterocyclic products.
amino ester fluorine-containing amine product yield (two steps) 15%, (±)-24a
12%, (±)-24b

27%, (±)-24c
38%, (±)-24d
27%, (±)-24e Table 3 . Synthesis of azepane β-amino esters 24a-e.
Experimental Section
General procedure for the synthesis of fluorine-containing N-heterocyclic β-amino esters by oxidative ring cleavage followed by reductive amination To a stirred solution of β-amino ester (2 mmol) NaIO4 (1.5 equiv) was added in THF/H2O (25 mL/2 mL). After stirring for 1 h at 20 °C under argon atmosphere, H2O was added (40 mL). Then the mixture was extracted with CH2Cl2 (3×20 mL) and the combined extract was dried over Na2SO4.
The crude dialdehyde product was immediately used for reductive amination without purification.
Fluorinated or polyfluorinated amines (1 equiv) were added to the solution in CH2Cl2 (30 mL) and the mixture was stirred at 20 °C for 10 minutes. Next NaBH3CN (1 equiv) and AcOH (2 drops) were added and stirring was continued for another 4 h at 20 °C. Then the reaction mixture was diluted with H2O (20 mL) and extracted with CH2Cl2 (3×20 mL). The combined organic layer was dried (Na2SO4) and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc). Hz, CH2F), 126.9, 127.6, 128.4, 128.7, 131.3, 134.6, 166.3, 173.4; 19 F-NMR (471 MHz, CDCl3): 
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